Search

everythinglearnresearchcommunity

for

Search:↓

The N-K GM Series offers treatments for full hair restoration and permanent hair removal, claiming 100% effectiveness without side effects.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

It's unclear if COVID-19 vaccination causes SLE; more research is needed.

Ebastine may help regrow hair in alopecia areata patients.

Genetic screening for NUDT15 polymorphisms is crucial for patients taking azathioprine, especially in Asians.

The UK Intellectual Property Office allows granting of supplementary protection certificates with negative terms.

Targeted immune modulation can help achieve stable remission in alopecia areata.

Farudodstat may help treat alopecia areata by protecting hair follicles.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Certain microRNAs may help treat alopecia areata by targeting immune pathways.

Chemical lumbar sympathectomy is an effective and safe treatment for idiopathic livedo reticularis.

Mycophenolate mofetil can effectively treat autoimmune hepatitis when standard drugs fail.

Dysplastic nevi have unique gene expressions, making them distinct from common melanocytic nevi.

Mutations in the hHb6 gene cause the hair disorder monilethrix.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Serum calprotectin is not a reliable marker for alopecia areata activity.

Genetic differences affect COVID-19 severity and treatment effectiveness.

NSG mice had the most mites, and genetic factors affect immune response and susceptibility.

Pemphigus vulgaris involves specific immune cells and B cells that produce antibodies causing skin blisters.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

Adding fetal calf serum to the medium kept Merkel cells alive and changed their shape.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

New medicines that block a specific pathway are showing promise for treating severe hair loss but need more testing for safety and effectiveness.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

Secukinumab treatment may cause HBV reactivation and hair discoloration.

Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

The new cream with N-acetyl glucosamine didn't change skin color after 8 weeks.

Baricitinib is the most effective treatment for alopecia areata.